<p>A. Flow cytometric analysis for expression of GFP and HIV-1 p24 Gag at the indicated times post-infection. Non-transduced CEMx174 cells were mixed with transduced cells expressing the maC46 inhibitors such that approximately 25–30% of the cells were GFP<sup>+</sup>. Mixtures of cells were then infected with HIV-1<sub>NL4-3</sub> at a MOI of 10<sup>−3</sup> TCID<sub>50</sub> per cell. Expression of HIV-1 p24 Gag and GFP were determined by flow cytometry on days 5, 9, 14 and 21. B. Survival advantage of cells expressing maC46 following HIV-1 infection. Mixtures of non-transduced CEMx174 cells and transduced cells expressing the shI, maC46, and antisense <i>env</i> inhibitors, or transduced with the HJ57 control vector (GFP) were generated ...
<p>(A) Wt and Daxx KO MEFs were transduced with increasing doses of HIV-1 vector and the percentage ...
<div><p>(A) Dose-independent restriction of several CA mutants in nondividing cells. Nondividing cel...
<p>TE671 cells (A), Jurkat T cells (B), human PBMC (C), or human CD4<sup>+</sup> T cells (D) were tr...
Although a variety of genetic strategies have been developed to inhibit HIV replication, few direct ...
<p>Non-transduced CEMx174 cells (NT) and CEMx174 cells transduced with vectors expressing the indica...
<p>(A) Chimeric vectors were generated in which the coding sequence for HIV-1 CA amino acid residues...
HIV currently infects 35 million people worldwide and antiretroviral treatments are expensive, lifel...
<p>A) HIV-1 viral fusion in PSC-macrophages. The percentage of fusion of HIV-1 virions was normalise...
<p>(A) Transduction efficiency of VSV G-pseudotyped two-part vectors for HIV-1<sub>NL4-3</sub>GFP (w...
<p><b>A)</b> HeLa TZM-bl cells were transfected twice with control or Vps26 siRNA. Forty-eight hours...
<p><b>(A)</b> Relative infectivity of an HIV-1 GFP-reporter virus without any label (Control) or wit...
<p>A) Design of the reporter virus used in this study. The murine reporter HSA gene ensures a rapid ...
Background: The gene therapeutic Cal-1 comprises the anti-HIV agents: (i) sh5, a short hairpin RNA t...
<p>MDMs differentiated in presence of GM-CSF for 5 days were infected with VSV-G pseudotyped HIV-1-e...
<p>(<i>A</i>) Estimation of cellular infectivity by HIV-1 in HOS, cybrid and ρ<sup>0</sup> cells. HO...
<p>(A) Wt and Daxx KO MEFs were transduced with increasing doses of HIV-1 vector and the percentage ...
<div><p>(A) Dose-independent restriction of several CA mutants in nondividing cells. Nondividing cel...
<p>TE671 cells (A), Jurkat T cells (B), human PBMC (C), or human CD4<sup>+</sup> T cells (D) were tr...
Although a variety of genetic strategies have been developed to inhibit HIV replication, few direct ...
<p>Non-transduced CEMx174 cells (NT) and CEMx174 cells transduced with vectors expressing the indica...
<p>(A) Chimeric vectors were generated in which the coding sequence for HIV-1 CA amino acid residues...
HIV currently infects 35 million people worldwide and antiretroviral treatments are expensive, lifel...
<p>A) HIV-1 viral fusion in PSC-macrophages. The percentage of fusion of HIV-1 virions was normalise...
<p>(A) Transduction efficiency of VSV G-pseudotyped two-part vectors for HIV-1<sub>NL4-3</sub>GFP (w...
<p><b>A)</b> HeLa TZM-bl cells were transfected twice with control or Vps26 siRNA. Forty-eight hours...
<p><b>(A)</b> Relative infectivity of an HIV-1 GFP-reporter virus without any label (Control) or wit...
<p>A) Design of the reporter virus used in this study. The murine reporter HSA gene ensures a rapid ...
Background: The gene therapeutic Cal-1 comprises the anti-HIV agents: (i) sh5, a short hairpin RNA t...
<p>MDMs differentiated in presence of GM-CSF for 5 days were infected with VSV-G pseudotyped HIV-1-e...
<p>(<i>A</i>) Estimation of cellular infectivity by HIV-1 in HOS, cybrid and ρ<sup>0</sup> cells. HO...
<p>(A) Wt and Daxx KO MEFs were transduced with increasing doses of HIV-1 vector and the percentage ...
<div><p>(A) Dose-independent restriction of several CA mutants in nondividing cells. Nondividing cel...
<p>TE671 cells (A), Jurkat T cells (B), human PBMC (C), or human CD4<sup>+</sup> T cells (D) were tr...